Sabile Trimm

Associate Director, Integrated Drug Development

About Sabile Trimm

Sabile Trimm performs toxicokinetic/pharmacokinetic reporting for pre-clinical studies and is an expert in GLP regulatory requirements. She also generates SEND files with the TK reports and provides client support as they take their drugs from discovery through to IND submission. Being able to turn around TK reports quickly without compromising quality has created a loyal clientele.  Sabile is known for her business acumen, commitment to service and client relationships, and her ability to recruit new clients through business development initiatives.

Sabile has a Bachelor’s degree in Chemistry from the University of Toronto and a Master’s degree in Chemical Engineering from the University of Waterloo. Initially working as a polymer engineer in R&D, she switched to the pharmaceutical world in 2007.  Sabile worked as a pharmacokineticist for Charles River Labs for 9 years, then co-founded Montreal Pharmacokinetics Inc (MTL-PK) in 2017, a PK-focused CRO with GLP accreditation. MTL-PK was acquired by Certara in 2018, where Sabile is now an Associate Director.

Sabile lives on a certified organic farm and has a quarter acre permaculture vegetable garden. She is passionate about food security, biodiversity, food preservation, off-grid living, zero waste, and domestic history. She is also a vocal advocate for democracy, free speech, civil liberties, and property rights.